JP2014506259A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506259A5 JP2014506259A5 JP2013548861A JP2013548861A JP2014506259A5 JP 2014506259 A5 JP2014506259 A5 JP 2014506259A5 JP 2013548861 A JP2013548861 A JP 2013548861A JP 2013548861 A JP2013548861 A JP 2013548861A JP 2014506259 A5 JP2014506259 A5 JP 2014506259A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cdr
- ligand
- antibody
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11151073 | 2011-01-17 | ||
| EP11151073.1 | 2011-01-17 | ||
| US201161434989P | 2011-01-21 | 2011-01-21 | |
| US61/434,989 | 2011-01-21 | ||
| EP11168328.0 | 2011-05-31 | ||
| EP11168328 | 2011-05-31 | ||
| US201161493002P | 2011-06-03 | 2011-06-03 | |
| US61/493,002 | 2011-06-03 | ||
| EP11187212.3 | 2011-10-31 | ||
| EP11187212 | 2011-10-31 | ||
| PCT/EP2012/050633 WO2012098113A1 (en) | 2011-01-17 | 2012-01-17 | Il-21 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014506259A JP2014506259A (ja) | 2014-03-13 |
| JP2014506259A5 true JP2014506259A5 (enExample) | 2015-03-05 |
Family
ID=46515179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548861A Withdrawn JP2014506259A (ja) | 2011-01-17 | 2012-01-17 | Ｉｌ−２１リガンド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130323259A1 (enExample) |
| EP (1) | EP2665750A1 (enExample) |
| JP (1) | JP2014506259A (enExample) |
| CN (1) | CN103443124A (enExample) |
| WO (1) | WO2012098113A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006340750B2 (en) | 2005-11-28 | 2013-03-07 | Zymogenetics, Inc. | IL-21 antagonists |
| EP2746293A1 (en) | 2012-12-21 | 2014-06-25 | Novo Nordisk A/S | Anti-IL21 antibodies for use in the treatment of cardiovascular diseases |
| US20140178395A1 (en) | 2012-12-21 | 2014-06-26 | Novo Nordisk A/S | Treatment of nephropathy |
| WO2015118119A1 (en) * | 2014-02-07 | 2015-08-13 | Novo Nordisk A/S | Antibody process |
| AR099625A1 (es) | 2014-03-21 | 2016-08-03 | Lilly Co Eli | Anticuerpos de il-21 |
| WO2015169789A1 (en) | 2014-05-07 | 2015-11-12 | Novo Nordisk A/S | Treatment of diabetes type 1 using glp-1 and anti-il-21 |
| JP6449338B2 (ja) | 2014-06-06 | 2019-01-09 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | グルココルチコイド誘導腫瘍壊死因子受容体（ｇｉｔｒ）に対する抗体およびその使用 |
| JP6812364B2 (ja) | 2015-06-03 | 2021-01-13 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 癌診断用抗ｇｉｔｒ抗体 |
| CN108738324B (zh) | 2015-11-19 | 2022-06-21 | 百时美施贵宝公司 | 抗糖皮质激素诱导的肿瘤坏死因子受体(gitr)抗体及其用途 |
| KR20200006115A (ko) | 2017-05-16 | 2020-01-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-gitr 효능제 항체에 의한 암의 치료 |
| WO2021119482A1 (en) | 2019-12-13 | 2021-06-17 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| US12012441B2 (en) | 2020-10-26 | 2024-06-18 | Neptune Biosciences Llc | Engineered human IL-21 cytokines and methods for using the same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2506665T3 (es) | 1999-12-23 | 2014-10-13 | Genentech, Inc. | Polipéptidos homólogos IL-17 e IL-17R y usos terapéuticos de los mismos |
| SG177012A1 (en) * | 2002-05-20 | 2012-01-30 | Abmaxis Inc | Generation and selection of protein library in silico |
| CN102746399B (zh) * | 2002-12-24 | 2016-03-02 | 里纳特神经系统学公司 | 抗ngf抗体及其使用方法 |
| ITRM20040586A1 (it) * | 2004-11-29 | 2005-02-28 | Giuliani Spa | Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico. |
| AU2006340750B2 (en) * | 2005-11-28 | 2013-03-07 | Zymogenetics, Inc. | IL-21 antagonists |
| JP2009520468A (ja) * | 2005-12-23 | 2009-05-28 | ヴィヴェンティア バイオテック インコーポレーティッド | 融合タンパク質ライブラリーの作製法およびスクリーニング法、ならびにそれらの使用 |
| WO2009047360A1 (en) * | 2007-10-11 | 2009-04-16 | Novo Nordisk A/S | Il-21 antibodies |
| EP2217268B1 (en) * | 2007-12-07 | 2016-05-04 | ZymoGenetics, Inc. | Anti-human il-21 monoclonal antibodies |
| WO2009132821A1 (en) * | 2008-04-28 | 2009-11-05 | Giuliani International Limited | Interleukin (il-21) binding proteins and methods of making and using same |
| US8193321B2 (en) * | 2008-09-03 | 2012-06-05 | Genentech, Inc. | Multispecific antibodies |
| CA2760525A1 (en) * | 2009-04-29 | 2010-11-04 | Mark Cunningham | Toll-like receptor 3 antagonists |
-
2012
- 2012-01-17 EP EP12708706.2A patent/EP2665750A1/en not_active Withdrawn
- 2012-01-17 WO PCT/EP2012/050633 patent/WO2012098113A1/en not_active Ceased
- 2012-01-17 CN CN2012800138627A patent/CN103443124A/zh active Pending
- 2012-01-17 JP JP2013548861A patent/JP2014506259A/ja not_active Withdrawn
- 2012-01-17 US US13/979,430 patent/US20130323259A1/en not_active Abandoned